|
|
Volumn 11, Issue 9, 2010, Pages 813-814
|
|
Expression of concern-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: A substudy of the EORTC 10994/BIG 00-01 clinical trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RESEARCH;
CLINICAL RESEARCH;
HUMAN;
MEDICAL DECISION MAKING;
METHODOLOGY;
NOTE;
PHARMACOGENETICS;
PREDICTION;
PRIORITY JOURNAL;
PUBLICATION;
STATISTICAL ANALYSIS;
STATISTICAL MODEL;
TREATMENT RESPONSE;
VALIDATION PROCESS;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
BREAST NEOPLASMS;
DRUG RESISTANCE;
FEMALE;
GENE EXPRESSION PROFILING;
GENETICS;
STANDARDS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE EXPRESSION PROFILING;
HUMANS;
NEOADJUVANT THERAPY;
RESEARCH DESIGN;
ANTINEOPLASTIC AGENT;
|
|
EID: 77956182793
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(10)70185-6 Document Type: Note |
|
Times cited : (8)
|
|
References (2)
|
